Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kostic

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Vojnosanitetski Pregled|January 5, 2002
[Clinical study of administration of abciximab--a monoclonal antibody to platelet glycoprotein IIb/IIIa in percutaneous intracoronary interventions]S Obradovic, B Gligic, G Nikovic, et al.
Clinical Genetics|February 3, 2016
Molecular and phenotypic characteristics of seven novel mutations causing branched-chain organic aciduriasM Stojiljkovic, K Klaassen, M Djordjevic, et al.
Neurology|March 2, 2012
Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosisS Mesaros, M A Rocca, K Kacar, et al.
Hippokratia|May 15, 2023
Total costs of inpatient treatment for COVID-19 in a tertiary hospital in SerbiaP S Sazdanovic, S Milisavljevic, D R Milovanovic, et al.
Open Medicine (Warsaw, Poland)|April 8, 2024
Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional studyAleksandra D Petrovic, Ana M Barjaktarevic, Olivera Z Kostic, et al.
Open Medicine (Warsaw, Poland)|June 15, 2026
Fever of unknown origin: cost of illness studyIvana Lesnjak, Biljana Popovska Jovicic, Katarina Jankovic, et al.
Journal of Medical Genetics|January 8, 2008
CDKN2A mutations and melanoma risk in the Icelandic populationA M Goldstein, S N Stacey, J H Olafsson, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia-An Inpatient Welfare Institution-Based Cross-Sectional StudyAleksandra D Petrovic, Ana M Barjaktarevic, Olivera Z Kostic, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Vojnosanitetski Pregled|January 5, 2002
[Clinical study of administration of abciximab--a monoclonal antibody to platelet glycoprotein IIb/IIIa in percutaneous intracoronary interventions]S Obradovic, B Gligic, G Nikovic, et al.
Clinical Genetics|February 3, 2016
Molecular and phenotypic characteristics of seven novel mutations causing branched-chain organic aciduriasM Stojiljkovic, K Klaassen, M Djordjevic, et al.
Neurology|March 2, 2012
Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosisS Mesaros, M A Rocca, K Kacar, et al.
Hippokratia|May 15, 2023
Total costs of inpatient treatment for COVID-19 in a tertiary hospital in SerbiaP S Sazdanovic, S Milisavljevic, D R Milovanovic, et al.
Open Medicine (Warsaw, Poland)|April 8, 2024
Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional studyAleksandra D Petrovic, Ana M Barjaktarevic, Olivera Z Kostic, et al.
Open Medicine (Warsaw, Poland)|June 15, 2026
Fever of unknown origin: cost of illness studyIvana Lesnjak, Biljana Popovska Jovicic, Katarina Jankovic, et al.
Journal of Medical Genetics|January 8, 2008
CDKN2A mutations and melanoma risk in the Icelandic populationA M Goldstein, S N Stacey, J H Olafsson, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Safety Profile of Antipsychotics as Predictors of the Quality of Life in Patients with Schizophrenia-An Inpatient Welfare Institution-Based Cross-Sectional StudyAleksandra D Petrovic, Ana M Barjaktarevic, Olivera Z Kostic, et al.
Pageof 2